(PharmaNewsWire.Com, September 19, 2017 ) According to the report Europe Tumor Ablation Market, published by Market Data Forecast the Market was worth USD 86.25 billion in 2016 and estimated to be growing at a CAGR of 11.6%, to reach USD 149.31 million by 2021. Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung and liver.
Rising Prevalence of cancer is proportional to the growth of tumor ablation market. According to the recent statistics published by the WHO, cancer accounts for 13% of the deaths worldwide. Cancer incidence is expected to increase by 70% over the next couple of decades.
Europe Tumor Ablation Market is driven by key factors such as growing geriatric population across the continent, increasing number of people affected with cancer; technological advancements in the field of ablation. Increasing demand for minimally invasive cancer treatment procedures and rising awareness regarding the benefits offered by ablation procedures over the conventional surgical procedures are also some of the factors boosting the growth of the market. However challenges related to ablation procedures and stringent regulatory guidelines and high costs are some of the factors restraining the market growth.
Europe tumor ablation market is segmented by technology, treatment and application. By technology the market is further sub-segmented into Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices is the dominating technology segment accounting for a share of about 35% attributed to its crucial role in solid tumour removal in the body. Based on treatment the market is segmented as Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Surgical Procedures segment accounted for a prominent share of around 37% owing to increasing prevalence of liver and breast cancers. Based on application Europe tumor ablation market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer.
On the basis of geography Europe Tumor Ablation market is segmented into United Kingdom, France, Spain, Italy and Germany. Europe is the second largest market for tumor ablation devices owing to rising prevalence of cancer. Within Europe, United Kindgom is the largest market.
Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
